Prevalence and mechanism of pulmonary hypertension in sickle cell disease: a prospective multicentre french study
F. Parent, D. Bachir, F. Lionnet, J. Inamo, L. Savale, F. Driss, G. Loko, S. Bennani, B. Maître, R. Girot, F. Galacteros, G. Simonneau (Clamart, Créteil, Paris, Le Kremlin Bicêtre, France; Fort de France, Le Lamentin, Martinique)
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Parent, D. Bachir, F. Lionnet, J. Inamo, L. Savale, F. Driss, G. Loko, S. Bennani, B. Maître, R. Girot, F. Galacteros, G. Simonneau (Clamart, Créteil, Paris, Le Kremlin Bicêtre, France; Fort de France, Le Lamentin, Martinique). Prevalence and mechanism of pulmonary hypertension in sickle cell disease: a prospective multicentre french study. Eur Respir J 2009; 34: Suppl. 53, 170
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Pulmonary arterial hypertension associated with primary Sjögren's syndrome: a multicentre cohort study from China Source: Eur Respir J, 56 (5) 1902157; 10.1183/13993003.02157-2019 Year: 2020
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study Source: ERJ Open Res, 8 (1) 00443-2021; 10.1183/23120541.00443-2021 Year: 2022
Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019 Year: 2019
Prospective study of lung function in children with sickle cell disease Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003
Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010
Late Breaking Abstract - COVID-19 in patients with pulmonary hypertension: a national prospective cohort study Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020
Use of bosentan for the treatment of pulmonary arterial hypertension in Spain: a multicenter, retrospective, observational study Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009
Multi-institutional prospective registry in pulmonary hypertension associated with respiratory disease in Japan. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018
Prospective cohort study of the alternate healthy eating index-2010 and risk of chronic obstructive pulmonary disease in US women and men Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease Year: 2013
Pulmonary vascular disease (PVD) in patients with Sjögren syndrome - a prospective cross-sectional study Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019
Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976–2013 Source: Eur Respir J , 49 (2) 1601290; DOI: 10.1183/13993003.01290-2016 Year: 2017
Association between chronic obstructive pulmonary disease and endometriosis: a population-based cohort study Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020
PEGASUS - the effects of commercial air travel on patients suffering from pulmonary hypertension - a prospective, multicenter, multinational study Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018
Feasibility of home spirometry in patients with chronic graft-versus-host disease: a prospective observational study Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016
A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019
A multicenter case-control study of genetic risk factors for portopulmonary hypertension (POPH) Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007
Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial Source: ERJ Open Res, 5 (3) 00110-2019; 10.1183/23120541.00110-2019 Year: 2019